Description
Myelin is a founders-turned-investors venture capital firm that partners with outlier entrepreneurs to build unimagined companies. The firm is industry agnostic, investing from seed through Series A in founders with electrifying ideas for a future they want to live in. Its team includes General Partners, an Investment Partner, a Principal, a CFO, and a Venture Partner, several of whom are former founders themselves. Myelin's portfolio spans a wide range of sectors including biotech and healthcare (Aura Biosciences, Forta Health, Gameto, Curex, Choiz, CopilotIQ, Tympa Health, Vitara, Conceive, Contraline, Signatur Biosciences), fintech and financial services (Buenbit, Pomelo, Goin, Mujer Financiera, TravelX, Gondi), consumer and marketplace businesses (Cookunity, Houm, Vamos, Mama, Wally, Envoy), deep tech and space (Neurosity, Skyloom, Longshot, Terraform, Outpost, Efficient), and developer/enterprise tools (Commit, Humand, Inkeep, Berry Scale, Modern Intelligence). The firm typically serves early-stage founders across Latin America and globally who are building transformative products and services.